Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa Reimers

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Oncology Practice|May 16, 2017
Reply to C.D. Woodrell et alHanna K Sanoff, YunKyung Chang, Melissa Reimers, et al.
Journal of Oncology Practice|December 29, 2016
Hospice Utilization and Its Effect on Acute Care Needs at the End of Life in Medicare Beneficiaries With Hepatocellular CarcinomaHanna K Sanoff, YunKyung Chang, Melissa Reimers, et al.
Clinical Genitourinary Cancer|September 13, 2023
Does Chemo-Radiotherapy Improve Survival Outcomes vs. Radiotherapy Alone for High-Grade cT1 Urothelial Carcinoma of the Bladder?Neal Andruska, Michael R Waters, Benjamin W Fischer-Valuck, et al.
Nature Communications|November 14, 2022
Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistanceDhivya Sridaran, Surbhi Chouhan, Kiran Mahajan, et al.
European Urology Oncology|March 7, 2022
Association Between Local Radiation Therapy to the Primary Bladder Tumor and Overall Survival for Patients with Metastatic Urothelial Cancer Receiving Systemic ChemotherapyBenjamin W Fischer-Valuck, Sagar A Patel, Randall J Brenneman, et al.
Clinical Genitourinary Cancer|November 14, 2020
Management of Muscle-Invasive Bladder Cancer During a Pandemic: Impact of Treatment Delay on Survival Outcomes for Patients Treated With Definitive Concurrent ChemoradiotherapyBenjamin W Fischer-Valuck, Jeff M Michalski, Joanna G Harton, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Oncology Practice|May 16, 2017
Reply to C.D. Woodrell et alHanna K Sanoff, YunKyung Chang, Melissa Reimers, et al.
Journal of Oncology Practice|December 29, 2016
Hospice Utilization and Its Effect on Acute Care Needs at the End of Life in Medicare Beneficiaries With Hepatocellular CarcinomaHanna K Sanoff, YunKyung Chang, Melissa Reimers, et al.
Clinical Genitourinary Cancer|September 13, 2023
Does Chemo-Radiotherapy Improve Survival Outcomes vs. Radiotherapy Alone for High-Grade cT1 Urothelial Carcinoma of the Bladder?Neal Andruska, Michael R Waters, Benjamin W Fischer-Valuck, et al.
Nature Communications|November 14, 2022
Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistanceDhivya Sridaran, Surbhi Chouhan, Kiran Mahajan, et al.
European Urology Oncology|March 7, 2022
Association Between Local Radiation Therapy to the Primary Bladder Tumor and Overall Survival for Patients with Metastatic Urothelial Cancer Receiving Systemic ChemotherapyBenjamin W Fischer-Valuck, Sagar A Patel, Randall J Brenneman, et al.
Clinical Genitourinary Cancer|November 14, 2020
Management of Muscle-Invasive Bladder Cancer During a Pandemic: Impact of Treatment Delay on Survival Outcomes for Patients Treated With Definitive Concurrent ChemoradiotherapyBenjamin W Fischer-Valuck, Jeff M Michalski, Joanna G Harton, et al.
Pageof 1